RNS Number : 8171F
ProCook Group PLC
06 March 2024
6 March 2024
ProCook Group plc
Director Declaration
ProCook Group plc (the "Company") has been notified by Lee Tappenden, CEO of the Company, that the following companies have entered liquidation or administration processes. Mr. Tappenden served as a director of these companies as subsidiaries of his previous employer, Amyris, Inc. (which filed for Chapter 11 bankruptcy in August 2023). Mr Tappenden served notice of his resignation as President Amyris International on 4 July 2023.
· Amyris UK Trading Limited entered creditors' voluntary liquidation on 18 December 2023. Mr. Tappenden resigned as a director on 11 September 2023;
· Beauty Labs International Limited entered creditors' voluntary liquidation on 29 December 2023. Mr. Tappenden resigned as a director on 14 August 2023; and
· MG Empower Limited appointed an administrator on 15 February 2024. Mr. Tappenden resigned as a director on 4 August 2023.
This notification satisfies the Company's obligations under paragraph 9.6.14(1) of the Listing Rules.
For further information please contact:
|
ProCook Group plc Lee Tappenden, Chief Executive Officer Dan Walden, Chief Financial Officer
|
investor.relations@procook.co.uk |
|
MHP Group (Financial PR Adviser) Katie Hunt Catherine Chapman
|
procook@mhpgroup.com Tel: 44 (0)7711 191 518 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.